{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:29:13Z","timestamp":1793788153955,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urology.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:17:18Z","timestamp":1787552238000},"page":"98-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Association of 5-\u03b1 Reductase Inhibitors for Benign Prostatic Hyperplasia With Development of Male Breast Disease and Erectile Dysfunction: A Retrospective Cohort Study of TriNetX Database"],"prefix":"10.1016","volume":"216","author":[{"given":"Renil S.","family":"Titus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansh","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archan","family":"Khandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-5502","authenticated-orcid":false,"given":"Hemendra N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.08.018_bib1","unstructured":"2025National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. Urologic Diseases in America - NIDDK. Accessed December 13, 2025. https:\/\/www.niddk.nih.gov\/about-niddk\/strategic-plans-reports\/urologic-diseases-in-america."},{"key":"10.1016\/j.urology.2026.08.018_bib2","unstructured":"Gynecomastia and Breast Cancer during Finasteride Therapy | New England Journal of Medicine [Internet]. 2026. . Accessed May 14, 2026. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJM199609123351116."},{"key":"10.1016\/j.urology.2026.08.018_bib3","unstructured":"Breast Cancer in Men | Annals of Internal Medicine [Internet]. 2026. . Accessed May 14, 2026. . https:\/\/www.acpjournals.org\/doi\/10.7326\/0003-4819-137-8-200210150-00013."},{"key":"10.1016\/j.urology.2026.08.018_bib4","unstructured":"GOV.UK [Internet]2026Finasteride: potential risk of male breast cancer. Accessed May 14, 2026. https:\/\/www.gov.uk\/drug-safety-update\/finasteride-potential-risk-of-male-breast-cancer."},{"key":"10.1016\/j.urology.2026.08.018_bib5","first-page":"980","article-title":"Finasteride use and risk of male breast cancer: a case-control study using individual-level registry data from Denmark, Finland, and Sweden","volume":"28","author":"Kj\u00e6rulff","year":"2019","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"10.1016\/j.urology.2026.08.018_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cam4.1273","article-title":"Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries","volume":"7","author":"Meijer","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.urology.2026.08.018_bib7","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.juro.2013.04.132","article-title":"Male breast cancer and 5\u03b1-reductase inhibitors finasteride and dutasteride","volume":"190","author":"Bird","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.08.018_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.semradonc.2019.05.009","article-title":"Use of claims data for cost and cost-effectiveness research","volume":"29","author":"Shih","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.urology.2026.08.018_bib9","unstructured":"Brown J.Is your real-world data research-ready? TriNetX [Internet]. 2024. Accessed May 14, 2026. . https:\/\/trinetx.com\/blog\/is-your-real-world-data-research-ready\/."},{"key":"10.1016\/j.urology.2026.08.018_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2026.111037","article-title":"Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: a retrospective cohort study using the TriNetX database","volume":"44","author":"Velasquez","year":"2026","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2026.08.018_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urology.2026.08.018_bib12","unstructured":"TriNetX Help Center [Internet]. 2025In Compare Outcomes, how are patients matched when balancing cohorts? Accessed April 13, 2025. https:\/\/support.trinetx.com\/hc\/en-us\/articles\/360011978033-In-Compare-Outcomes-how-are-patients-matched-when-balancing-cohorts."},{"key":"10.1016\/j.urology.2026.08.018_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910530403","article-title":"Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors","volume":"53","author":"Sasco","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2026.08.018_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7819-6-58","article-title":"Male breast cancer: is the scenario changing","volume":"6","author":"Contractor","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urology.2026.08.018_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men: a population-based study","volume":"101","author":"Giordano","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.08.018_bib16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1245\/s10434-010-1468-3","article-title":"Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration","volume":"18","author":"Gnerlich","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urology.2026.08.018_bib17","unstructured":"Research C for DE and. FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products. FDA [Internet].2026Accessed May 14, 2026. https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/fda-alerts-health-care-providers-compounders-and-consumers-potential-risks-associated-compounded."},{"key":"10.1016\/j.urology.2026.08.018_bib18","unstructured":"Al-Horani R.A., Dutasteride Patel P.StatPearls [Internet]2026. Treasure Island, FL: StatPearls Publishing. Accessed May 14, 2026 . http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK603726\/."},{"key":"10.1016\/j.urology.2026.08.018_bib19","unstructured":"2025Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia - ClinicalKey [Internet]. Accessed December 13, 2025. https:\/\/www.clinicalkey.com\/?adobe_mc=MCMID%3D07839114849995945223543455851251085980%7CMCORGID%3D4D6368F454EC41940A4C98A6%2540AdobeOrg%7CTS%3D1765682806#!\/content\/journal\/1-s2.0-S1526820918308371."},{"key":"10.1016\/j.urology.2026.08.018_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jsxm.2016.07.006","article-title":"Effect of 5\u03b1-reductase inhibitors on sexual function: a meta-analysis and systematic review of randomized controlled trials","volume":"13","author":"Liu","year":"2016","journal-title":"J Sex Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526005285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526005285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:03:22Z","timestamp":1793786602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429526005285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"alternative-id":["S0090429526005285"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.08.018","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of 5-\u03b1 Reductase Inhibitors for Benign Prostatic Hyperplasia With Development of Male Breast Disease and Erectile Dysfunction: A Retrospective Cohort Study of TriNetX Database","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}